Mercy Hospital and Medical Center now called Insight Hospital and Medical Center Chicago is a 414-bed general medical and surgical Catholic teaching hospital in Chicago, Illinois. Established in 1852, the hospital was the first chartered hospital in Chicago.

There are 414 beds in Mercy Hospital and Medical Center.

During the past decade, Mercy Hospital and Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 17 clinical trials were completed, i.e. on average, 1700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital and Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "Eastern Cooperative Oncology Group" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "American College of Surgeons" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital and Medical Center" are "Breast Cancer" (3 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (2 trials), "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11" (2 trials), "Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11" (2 trials) and "Adult Acute Myeloid Leukemia in Remission" (2 trials). Many other conditions were trialed in "Mercy Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Mercy Hospital and Medical Center" are "Drug" (34 trials), "Biological" (8 trials), "Other" (8 trials), "Radiation" (8 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "leucovorin calcium" (5 trials), "fluorouracil" (4 trials), "radiation therapy" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital and Medical Center" are 32 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Hospital and Medical Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Mercy Hospital and Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital and Medical Center, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".